"...[If] the United States committed itself to direct financing of biomedical research, with all of the output being put in the public domain. This means that new drugs, like the Hepatitis C drug Solvaldi, could be sold for a few hundred dollars a treatment, as opposed to its US list price for Sovaldi of $84,000...."

http://goo.gl/OgRdxA